Institutions Holding Call Options on Arbutus Biopharma Corp (ABUS)
This table provides information about the call option holders of Arbutus Biopharma Corp (ABUS). We have compiled data on the institutions that hold call options on the stock, with a total of 2.31 Million call options outstanding, which have been reported (via 13F filing form) to have a value of $7.36 Million at the end of the reported quarter. These call option holders have the right, but not the obligation, to buy AAPL shares at a specified price within a certain time frame.
| Holding | Report Date | calls Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Squarepoint Ops LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
1,270,000
calls
|
$4.04 Million
0.01% of portfolio
|
Q3 2024
Reduced 12.11%
|
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
Nov 14, 2024 Q3 2024 |
371,800
calls
|
$1.18 Million
0.0% of portfolio
|
N/A
|
|
|
Citigroup Inc
|
Nov 12, 2024 Q3 2024 |
317,400
calls
|
$1.01 Million
0.0% of portfolio
|
N/A
|
|
|
Wolverine Trading, LLC
Chicago, IL |
Nov 14, 2024 Q3 2024 |
278,400
calls
|
$885,312
0.0% of portfolio
|
N/A
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Nov 14, 2024 Q3 2024 |
54,300
calls
|
$172,674
0.0% of portfolio
|
N/A
|
|
|
Gts Securities LLC
New York, NY |
Nov 13, 2024 Q3 2024 |
21,200
calls
|
$67,416
0.0% of portfolio
|
N/A
|